The Anifrolumab PRIM Program

计划入组 240 人 · 首次发布于 2025 年 1 月 28 日

Randomized Clinical Trial of Standard FMT Treatments

首次发布于 2021 年 1 月 29 日

Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Cancer

计划入组 52 人 · 首次发布于 2026 年 8 月 14 日

PRIM-DJ2727

CU-06

CU-01

CU CHEMIE UETIKON GmbH

Germany

CU Anschutz Medical Campus

United States

CHULALONGKORN UNIVERSITY

Thailand

Engineered Nanozymes Reprogram the Colorectal Cancer Microenvironment to Overcome Chemoresistance and Immune Exclusion

Cutia Therapeutics' CU-40102 Demonstrates Efficacy in Phase III Trial for Androgenetic Alopecia

PRIM-ER Trial Finds Palliative Care Training in Emergency Departments Does Not Reduce Hospital Admissions